{
  "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9",
  "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc",
  "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides",
  "authorId": "mainz-biomed-nv",
  "authorName": "Mainz Biomed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 23,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/18",
  "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9",
  "deckJsonHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9.json",
  "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.82,
        "x": 0.09,
        "y": 0.41
      },
      "kind": "list",
      "text": "ColoAlert Holds Potential as a Blockbuster Early Detection Test for Colorectal Cancer.\nThis is Europe’s answer to Exact Sciences’ (~$25 billion market cap) ColoGuard product.\nDesigned for profitability, rapid commercial uptake, and broad consumer acceptance.\nIntellectual property is held through internal development of all critical reagents and formulations.\nMainz BioMed is already applying proprietary genetic testing methods for pancreatic cancer.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3913dce3-2952-48ca-bbc0-d01044679d95",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.82,
        "x": 0.09,
        "y": 0.35
      },
      "kind": "title",
      "text": "MAINZ BIOMED AIMS TO BECOME A LEADER IN THE MULTI-BILLION-DOLLAR COLORECTAL CANCER DIAGNOSTICS MARKET",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af551c7a-b0ac-4722-b13b-9f0ddd7aef15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.16,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "SUMMARY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc13db81-5ec5-4864-b1e0-7b3504e06b9c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "15807390-b007-4da2-99f7-f2014602be41",
      "evidence": "The slide features an action title 'MAINZ BIOMED AIMS TO BECOME A LEADER IN THE MULTI-BILLION-DOLLAR COLORECTAL CANCER DIAGNOSTICS MARKET'.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}